Biomarker FOXF2 for gastric cancer
US10294530B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2016 |
| Grant date | May 21, 2019 |
| Priority date | — |
| Expiry date | Dec 11, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4706
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides a method for diagnosing and determining prognosis of gastric cancer in a subject by detecting suppressed expression of the FOXF2 gene, which in some cases is due to elevated methylation level in the genomic sequence of this gene. A kit and device useful for such a method are also provided. In addition, the present invention provides a method for treating gastric cancer by increasing FOXF2 gene expression or activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.